DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Simon TG, Bonilla H, Yan P, Chung RT, Butt AA.
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: results from ERCHIVES.
Hepatology 2016;
64 (01) 47-57
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.